-
1
-
-
10744223381
-
Genetics and cytogenetics of multiple myeloma: A workshop report
-
Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: A workshop report. Cancer Res 2004; 64: 1546-1558.
-
(2004)
Cancer Res
, vol.64
, pp. 1546-1558
-
-
Fonseca, R.1
Barlogie, B.2
Bataille, R.3
-
2
-
-
0034876702
-
High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis
-
Bezieau S, Devilder MC, Avet-Loiseau H, et al. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Hum Mutat 2001; 18: 212-224.
-
(2001)
Hum Mutat
, vol.18
, pp. 212-224
-
-
Bezieau, S.1
Devilder, M.C.2
Avet-Loiseau, H.3
-
3
-
-
0035469865
-
Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation
-
Kalakonda N, Rothwell DG, Scarffe JH, Norton JD. Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation. Blood 2001; 98: 1555-1560.
-
(2001)
Blood
, vol.98
, pp. 1555-1560
-
-
Kalakonda, N.1
Rothwell, D.G.2
Scarffe, J.H.3
Norton, J.D.4
-
4
-
-
3242777803
-
Advances in biology of multiple myeloma: Clinical applications
-
Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: Clinical applications. Blood 2004; 104: 607-618.
-
(2004)
Blood
, vol.104
, pp. 607-618
-
-
Hideshima, T.1
Bergsagel, P.L.2
Kuehl, W.M.3
Anderson, K.C.4
-
5
-
-
33644680752
-
Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations
-
Agnelli L, Bicciato S, Mattioli M, et al. Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. J Clin Oncol 2005; 23: 7296-7306.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7296-7306
-
-
Agnelli, L.1
Bicciato, S.2
Mattioli, M.3
-
6
-
-
0141481982
-
Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells
-
Croonquist PA, Linden MA, Zhao F, Van Ness BG. Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells. Blood 2003; 102: 2581-2592.
-
(2003)
Blood
, vol.102
, pp. 2581-2592
-
-
Croonquist, P.A.1
Linden, M.A.2
Zhao, F.3
Van Ness, B.G.4
-
7
-
-
33744488766
-
Oncogenic ras mutations in myeloma cells selectively induce COX-2 expression which participates in enhanced adhesion to fibronectin and chemoresistance
-
Hoang B, Zhu L, Shi Y, et al. Oncogenic ras mutations in myeloma cells selectively induce COX-2 expression which participates in enhanced adhesion to fibronectin and chemoresistance. Blood 2006.
-
(2006)
Blood
-
-
Hoang, B.1
Zhu, L.2
Shi, Y.3
-
8
-
-
19944428341
-
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses
-
Fabris S, Agnelli L, Mattioli M, et al. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses. Genes Chromosomes Cancer 2005; 42: 117-127.
-
(2005)
Genes Chromosomes Cancer
, vol.42
, pp. 117-127
-
-
Fabris, S.1
Agnelli, L.2
Mattioli, M.3
-
9
-
-
20944437020
-
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
-
Mattioli M, Agnelli L, Fabris S, et al. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene 2005; 24: 2461-2473.
-
(2005)
Oncogene
, vol.24
, pp. 2461-2473
-
-
Mattioli, M.1
Agnelli, L.2
Fabris, S.3
-
10
-
-
0016804136
-
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
-
Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842-854.
-
(1975)
Cancer
, vol.36
, pp. 842-854
-
-
Durie, B.G.1
Salmon, S.E.2
-
11
-
-
0024811225
-
Ras oncogene mutation in multiple myeloma
-
Neri A, Murphy JP, Cro L, et al. Ras oncogene mutation in multiple myeloma. J Exp Med 1989; 170: 1715-1725.
-
(1989)
J Exp Med
, vol.170
, pp. 1715-1725
-
-
Neri, A.1
Murphy, J.P.2
Cro, L.3
-
12
-
-
13544275899
-
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma
-
Wuilleme S, Robillard N, Lode L, et al. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma. Leukemia 2005; 19: 275-278.
-
(2005)
Leukemia
, vol.19
, pp. 275-278
-
-
Wuilleme, S.1
Robillard, N.2
Lode, L.3
-
13
-
-
0142121516
-
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
-
Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
-
(2003)
Biostatistics
, vol.4
, pp. 249-264
-
-
Irizarry, R.A.1
Hobbs, B.2
Collin, F.3
-
15
-
-
0035752668
-
Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data
-
Schadt EE, Li C, Ellis B, Wong WH. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J Cell Biochem Suppl 2001; Suppl 37: 120-125.
-
(2001)
J Cell Biochem Suppl
, Issue.SUPPL. 37
, pp. 120-125
-
-
Schadt, E.E.1
Li, C.2
Ellis, B.3
Wong, W.H.4
-
16
-
-
0035942271
-
Significance analysis of microarrays applied to the ionizing radiation response
-
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5116-5121
-
-
Tusher, V.G.1
Tibshirani, R.2
Chu, G.3
-
17
-
-
11144235574
-
Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors
-
Rasmussen T, Kuehl M, Lodahl M, Johnsen HE, Dahl IM. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood 2005; 105: 317-323.
-
(2005)
Blood
, vol.105
, pp. 317-323
-
-
Rasmussen, T.1
Kuehl, M.2
Lodahl, M.3
Johnsen, H.E.4
Dahl, I.M.5
-
18
-
-
0027212420
-
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias
-
Corradini P, Ladetto M, Voena C, et al. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood 1993; 81: 2708-2713.
-
(1993)
Blood
, vol.81
, pp. 2708-2713
-
-
Corradini, P.1
Ladetto, M.2
Voena, C.3
-
19
-
-
20444422917
-
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome
-
Ladetto M, Vallet S, Trojan A, et al. Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome. Blood 2005; 105: 4784-4791.
-
(2005)
Blood
, vol.105
, pp. 4784-4791
-
-
Ladetto, M.1
Vallet, S.2
Trojan, A.3
-
20
-
-
0035254612
-
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
-
Chesi M, Brents LA, Ely SA, et al. Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 2001; 97: 729-736.
-
(2001)
Blood
, vol.97
, pp. 729-736
-
-
Chesi, M.1
Brents, L.A.2
Ely, S.A.3
-
21
-
-
0031039113
-
Transformation by ras modifies AP1 composition and activity
-
Mechta F, Lallemand D, Pfarr CM, Yaniv M. Transformation by ras modifies AP1 composition and activity. Oncogene 1997; 14: 837-847.
-
(1997)
Oncogene
, vol.14
, pp. 837-847
-
-
Mechta, F.1
Lallemand, D.2
Pfarr, C.M.3
Yaniv, M.4
-
22
-
-
0033621698
-
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation
-
Matsuo K, Owens JM, Tonko M, et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 2000; 24: 184-187.
-
(2000)
Nat Genet
, vol.24
, pp. 184-187
-
-
Matsuo, K.1
Owens, J.M.2
Tonko, M.3
-
23
-
-
0028908322
-
Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters
-
Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 1995; 10: 1461-1463.
-
(1995)
Oncogene
, vol.10
, pp. 1461-1463
-
-
Higashino, F.1
Yoshida, K.2
Noumi, T.3
Seiki, M.4
Fujinaga, K.5
|